Julie Luckart
Family · West Valley City, UTNPI 1831296508
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 96.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2022 at $62,394 and has fallen 98.4% since, to $985 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 245 payments — averaging $387.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$92K
- Daiichi Sankyo Inc.$839
- Novartis$510
- Lilly USA, LLC$262
- Merck$242
- AstraZeneca$178
- plus $1K from 25 others
What the payments were for
- Consulting fees$5,0205%
- Speaking & faculty fees$53,10056%
- Travel & lodging$30,05032%
- Food & beverage$6,2877%
- Education$3590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 118 | $91,603 |
| Daiichi Sankyo Inc. | 15 | $839 |
| Novartis | 32 | $510 |
| Lilly USA, LLC | 9 | $262 |
| Merck | 13 | $242 |
| AstraZeneca | 4 | $178 |
| Bristol Myers Squibb | 9 | $174 |
| Abbott | 2 | $124 |
| Seagen Inc. | 2 | $114 |
| E.r. Squibb & Sons, L.L.C. | 5 | $106 |
| Amgen | 3 | $65 |
| EMD Serono, Inc. | 4 | $60 |
| Incyte Corporation | 3 | $57 |
| Johnson & Johnson | 3 | $52 |
| Sanofi | 3 | $51 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $49 |
| Deciphera Pharmaceuticals Inc. | 2 | $41 |
| Pfizer | 2 | $33 |
| Beigene USA, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 2 | $31 |
| Eisai Inc. | 1 | $24 |
| AbbVie | 1 | $23 |
| Gilead | 1 | $21 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $18 |
| G1 Therapeutics, Inc. | 1 | $17 |
| GSK | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $14 |
| Geron Corporation | 1 | $14 |
| Sobi, Inc | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$94,817 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $136 |
| Gabapentin | 15 | $130 |
Paid to pharmacies, not to this prescriber.
Other family in West Valley City
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
- Shelby MillerSandy$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.